期刊文献+

前列腺特异性抗原启动子中雄激素反应元件的克隆和表达

Cloning and Expression of Androgen Response Elements of Prostate Specific Antigen Promoter
下载PDF
导出
摘要 目的:利用前列腺特异性抗原(PSA)启动子的组织特异性表达的特点,克隆出DNA片段并对其表达效率和组织特异性表达进行初步研究。方法:从前列腺组织中提取染色体组,PCR扩增出PSA启动子的两个上游片段a(含ARⅠ和ARⅡ)和b(含ARⅢ),利用报告基因egfp,分别构建3个载体pa-EGFP、pba-EGFP和p△ba-EGFP,并转染细胞HepG2、SMMC-7721、Hela和PC-3,观察表达情况。结果:pba-EGFP在前列腺癌细胞PC-3中的绿色荧光强度明显高于pa-EGFP和p△ba-EGFP,说明片段b(含ARⅢ)能显著增强PSA启动子的转录能力。pa-EGFP、p△ba-EGFP和pba-EGFP转染HepG2、SMMC-7721和Hela细胞,未见表达。结论:基于PSA启动子的组织特异性和调节序列构建的靶向载体,在治疗中加上功能蛋白将为临床实验提供一个坚实的平台。 Objective: To pruvide a possible targeted gene therapy scheme for prostate cancer, and explore the expression efficiency and tissue-specific expression of prostate specific antigen (PSA) promoter. Methods: Three plasmids with egfp, pa-EGFP( including ARⅠ ARⅡ) , pba-EGFP( including ARⅠ, AR Ⅱ , AR Ⅲ ) anti pA ba-EGFP( including ARⅠ, ARⅡ and mutated ARⅢ ) were designed, and the expression status was observed by transfecting into HepG2, SMMC-7721, Hela and PC-3. Results: In prostate cancer cell PC-3, pba-E(,FP expressed more GFP than pa-EGFP and p A ba-EGFP, which showed that ARm could notably increase the transcription efficiency of PSA promoter. Further, there was no GFP expression in HepG2, SMMC-7721 and Hela transfected with pa-EGFP, p△ba-EGFP and pba-EGFP. Conclusion: An expression vector based on elements of the PSA gene regulatory sequences has been developed and shown to be tightly regulated in a panel of cells from tissues of various origins. With the tissue-specific functional protein, it should provide a solid platform for clinical studies. Nail J Androl,2005,11 (12) :930-932
出处 《中华男科学杂志》 CAS CSCD 2005年第12期930-932,共3页 National Journal of Andrology
基金 江苏省医学重点学科基金(苏卫科教[2001]34号)
关键词 前列腺特异性抗原启动子 雄激素反应 克降 表达 prostate specific antigen promoter androgen response element cloning expression
  • 相关文献

参考文献7

  • 1Riegman PH,Vlietstra R J,van der Korput JA,et al.The promoter of the prostate-specific antigen gene contains a functional androgen responsive element [ J].Mol Endocrinol,1991,5(12) :1921-1930.
  • 2Tsai MJ,OMalley BW.Molecular mechanisms of action of steroid/thyroid receptor superfamily members [ J ].Annu Rev Biochem,1994,63:451-486.
  • 3Cleutjens KB,van der Korput HA,van Eekelen CC,et al.An androgen response element in a far upstream enhancer region is essential for high,androgen - regulated activity of the prostatespecific antigen promoter [ J ].Mol Endocrinol,1997,11 ( 2 ):148-161.
  • 4谢立平,郑祥毅,周晓峰.根治性前列腺切除术的进展[J].中华男科学杂志,2004,10(3):163-167. 被引量:4
  • 5Steiner MS,Gingrich JR.Gene therapy for prostate cancer:where are we now[J]? J Urol,2000,164(4) :1121-1136.
  • 6Pang S.Targeting and eradicating cancer cells by a prostate-specific vector carrying the diphtheria toxin A gene [ J ].Cancer Gene Ther,2000,7(7) :991-996.
  • 7Hart IR.Tissue specific promoters in targeting systemically delivered gene therapy[J].Semin Oncol,1996,23( 1 ) :154-158.

二级参考文献30

  • 1Holmberg L, Bill-Axelson A, Helgesen F, et al. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer [J]. N Engl J Med, 2002, 347(11):781-789.
  • 2Khan MA, Han M, Partin AW, et al. Long-term cancer control of radical prostatectomy in men younger than 50 years of age: update 2003[J]. Urology, 2003, 62(1):86-91.
  • 3Bhanot SM, Gopalakrishanan R. Smiley incision: a direct surgical approach for retropubic radical prostatectomy[J]. Urology, 2002, 60(1):149-151.
  • 4Muto G, Bardari F, Bozzo R, et al. Radical retropubic prostatectomy using endoscopic gastrointestinal anastomosis staplers[J]. Eur Urol, 2001, 39(Suppl 2):2-5.
  • 5Deliveliotis C, Protogerou V, Alargof E, et al. Radical prostatectomy: bladder neck preservation and puboprostatic ligament sparing-effects on continence and positive margins[J]. Urology, 2002, 60(5):855-858.
  • 6Paulson DF, Vieweg JW. Radical perineal prostatectomy: a model for evaluating local response of prostate therapy[J]. Crit Rev Oncol Hematol, 2002, 43(2):135-139.
  • 7Austoni E. Technical problems in achieving continence after perineal prostatectomy[J]. Arch Ital Urol Androl, 2001, 73(3):138-139.
  • 8Jakse G, Brehmer B, Borchers H, et al. Potency-sparing radical perineal prostatectomy[J]. Urologe A, 2003, 42(3):382-386.
  • 9Salomon L, Anastasiadis AG, Levrel O, et al. Location of positive surgical margins after retropubic, perineal, and laparoscopic radical prostatectomy for organ-confined prostate cancer[J].Urology, 2003, 61(2):386-390.
  • 10Salomon L, Levrel O, Anastasiadis AG, et al. Outcome and complications of radical prostatectomy in patients with PSA <10 ng/ml: comparison between the retropubic, perineal and laparoscopic approach[J]. Prostate Cancer Prostatic Dis, 2002, 5(4):285-290.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部